These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 27449742)

  • 1. Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD).
    Kumar J; Newton A
    Antiinflamm Antiallergy Agents Med Chem; 2016; 15(2):101-117. PubMed ID: 27449742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD).
    Kumar J; Newton AMJ
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):41-52. PubMed ID: 28034350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site Targeted Press Coated Delivery of Methylprednisolone Using Eudragit RS 100 and Chitosan for Treatment of Colitis.
    Jagdale S; Chandekar A
    Recent Pat Antiinfect Drug Discov; 2016; 11(1):32-43. PubMed ID: 26377799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
    Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
    Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and development of liposomes for colon targeted drug delivery.
    Gupta AS; Kshirsagar SJ; Bhalekar MR; Saldanha T
    J Drug Target; 2013 Feb; 21(2):146-60. PubMed ID: 23373543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology.
    Nandy BC; Mazumder B
    Curr Drug Deliv; 2014; 11(1):72-86. PubMed ID: 24783236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of nanocapsules for colon-targeted drug delivery system.
    Kshirsagar SJ; Bhalekar MR; Patel JN; Mohapatra SK; Shewale NS
    Pharm Dev Technol; 2012; 17(5):607-13. PubMed ID: 21428704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and development of extended-release micro particulate drug delivery system of solubilized rifaximin.
    Karanje RV; Bhavsar YV; Jahagirdar KH; Bhise KS
    AAPS PharmSciTech; 2013 Jun; 14(2):639-48. PubMed ID: 23516110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS; Elnaggar YS; Abdallah OY
    Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.
    Pertuit D; Moulari B; Betz T; Nadaradjane A; Neumann D; Ismaïli L; Refouvelet B; Pellequer Y; Lamprecht A
    J Control Release; 2007 Nov; 123(3):211-8. PubMed ID: 17889397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and relevance of physicochemical interactions among components of a novel multiparticulate formulation for colonic delivery.
    Singh BN; Kim KH
    Int J Pharm; 2007 Aug; 341(1-2):143-51. PubMed ID: 17509782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
    Jadiya S; Upmanyu N; Sathiyanarayanan A; Jain V; Dubey R; Buwade P
    J Pharm Sci; 2024 Jul; 113(7):1919-1926. PubMed ID: 38401631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and characterization of colon-specific drug delivery system containing paracetamol microsponges.
    Jain V; Singh R
    Arch Pharm Res; 2011 May; 34(5):733-40. PubMed ID: 21656358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of mucoadhesive nanosuspension of ciprofloxacin.
    Jain V; Kare P; Jain D; Singh R
    Acta Pol Pharm; 2011; 68(2):273-8. PubMed ID: 21485301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems--enhancement of oral bioavailability.
    Hashem FM; Al-Sawahli MM; Nasr M; Ahmed OA
    Drug Des Devel Ther; 2015; 9():3141-52. PubMed ID: 26150693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoadhesive platforms for targeted delivery to the colon.
    Varum FJ; Veiga F; Sousa JS; Basit AW
    Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
    Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
    Kshirsagar SJ; Bhalekar MR; Umap RR
    Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.